Sudarshan Chemical Industries Limited reported a 106% increase in standalone net profit to ₹290.3 crore for the financial year ended March 31, 2026, compared to ₹140.9 crore in the previous year. Revenue from operations for the year stood at ₹2,396.7 crore. The Board of Directors, at its meeting held on May 25, 2026, approved the audited financial results for the quarter and year ended March 31, 2026. On a consolidated basis, the company reported a net profit of ₹40.8 crore for the full year, while consolidated annual revenue surged to ₹9,787.2 crore versus ₹3,345.6 crore year-on-year.

Standalone Financial Performance

The company's standalone profit for the quarter ended March 31, 2026 was ₹120.4 crore. Total income for the year rose to ₹2,487.1 crore from ₹2,564.4 crore in the previous year. Earnings per share (EPS) for the year increased to ₹36.9 from ₹19.9 in the prior year. The auditors, SRBC & CO LLP, issued an unmodified opinion on the financial results.

The following table summarises the key standalone annual financial metrics:

Consolidated Performance

On a consolidated basis, Sudarshan Chemical delivered a net profit of ₹82.5 crore for Q4, compared to ₹0.4 crore in the year-ago period. Consolidated Q4 revenue more than doubled to ₹2,789.9 crore from ₹1,349.4 crore year-on-year. For the full year, consolidated net profit stood at ₹40.8 crore, with revenue surging to ₹9,787.2 crore. The company recorded an exceptional expense of ₹32 crore related to the statutory impact of new Labour Codes, comprising a gratuity impact of ₹30.1 crore and long-term compensated absences of ₹1.9 crore.

Acquisition Update

The company completed the acquisition of the global pigment business operations of the Heubach Group of Germany through its wholly owned subsidiary, Sudarshan Europe B.V. The acquisition was finalized at a purchase consideration of €139.6 million (approx. ₹1,277.0 crore). During the year, the company completed the purchase price allocation exercise, resulting in a decrease in capital reserve from ₹1,243.9 crore to ₹1,196.3 crore as of the closing date, adjusted retrospectively.

Dividend Declaration

The Board has recommended a final dividend of ₹5 per equity share, which translates to 250% on a face value of ₹2 each, for the financial year 2025-26. This dividend is subject to the approval of shareholders at the ensuing Annual General Meeting.

Sudarshan Chemical Industries Limited reported a strong financial performance for the quarter and financial year ended March 31, 2026, with consolidated revenue reaching ₹2,790 crore in Q4FY26. The company announced that its Business EBITDA stood at ₹247 crore for the quarter, driven by a 30% quarter-on-quarter growth in the acquired group's revenue run rate. Net debt reduced significantly from ₹934 crore in December 2025 to ₹755 crore by March 2026.

The company filed the investor presentation with the exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The presentation details the integration progress with Heubach, noting that the combined entity, "One Sudarshan," achieved an annual turnover of approximately €1 billion. Management highlighted that the acquired group's revenue run rate reached €61 million in Q4FY26 compared to €47 million in Q3FY26.

Q4FY26 Performance Highlights

The consolidated results for Q4FY26 show a recovery in sales, supported by increased purchases from Global Key Accounts and demand recovery in key regions like Europe and India. The company reported that inventory reduction efforts exceeded projections, reaching €29 million against a target of €20 million.

Integration and Outlook

Sudarshan Chemical stated that the integration with Heubach is progressing well, with the SAP S/4 HANA system implementation expected to be fully harmonized by December 2026. The company inaugurated a Global Capability Center (GCC) in Pune to centralize functions. Looking ahead, the management provided a projection for the acquired group, targeting Business EBITDA of €90-100 million over the next 3-4 years, up from €19 million in FY26. For FY27, the group projects sales of approximately €700 million and EBITDA of around €35 million.